Русский
English
عربي
Marcyrl Pharmaceutical Industries
Marcyrl Group is a leading global pharmaceutical manufacturer based in Egypt, certified according to EU GMP standards. The company provides innovative specialized medications in various therapeutic areas, with a strong presence in Africa and the Gulf Cooperation Council (GCC) countries.
Key Areas of Activity:
-
Pharmaceutical Products: Marcyrl offers a wide range of medications, including treatments for chronic conditions, hormonal products, and respiratory treatments.
-
Hormonal Medications: The company specializes in producing hormonal therapies, ensuring accessibility and effectiveness for patients.
-
Inhalers: Marcyrl develops and manufactures inhalers for the treatment of respiratory diseases, improving the quality of life for patients.
Achievements and News:
- Recently, Marcyrl launched an innovative product, Ruxotop, in collaboration with the Egyptian Drug Authority (EDA).
- Marcyrl was recognized by the EDA for its outstanding contribution to the development of Egypt's pharmaceutical exports in 2023.
Partnerships and Export:
Marcyrl Group actively collaborates with various partners and exports its products to 23 countries, including GCC, Levant, Africa, and aims to expand its presence in markets across Africa, CIS, GCC, and Latin America.
Brand products
